The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law FDA Compliance for Peptide Therapy and BPC 157 Holt Law BPC 157: The peptide with big claims and scant evidence STAT Orthopedic Use of BPC 157 Sports Med Review FDA takes first step in possible reversal of ban on some peptides The Washington Post